Med-IQ Logo
Get CME/CE
PDF Publication PDF Publication

Expert Perspectives in Individualized Contemporary Care for Short Bowel Syndrome


Time to Complete:
1 hour
Released:
12/23/13
Expires:
12/22/14

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)

PDF PublicationPDF Publication
Time to Complete:
1 hour

Released:
12/23/13

Expires:
12/22/14

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
Share on:
PDF PublicationPDF Publication

Share on:


Time to Complete:
1 hour
Released:
12/23/13
Expires:
12/22/14


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)


Overview: This publication, summarizing a roundtable discussion with 6 faculty experts, explores current perspectives in the management of short bowel syndrome (SBS). It covers topics such as clinical consequences, patient quality of life, and therapeutic advances and is designed to help clinicians understand malnutrition concerns, appreciate the process of intestinal adaptation, and optimally individualize therapy to mitigate the clinical and quality-of-life risks associated with the long-term use of parenteral nutrition.

Faculty

Alan L. Buchman, MD, MSPH
Center for Gastroenterology and Nutrition
Skokie, IL

John K. DiBaise, MD
Professor of Medicine
College of Medicine
Mayo Clinic
Rochester, MN
Consultant, Division of Gastroenterology & Hepatology
Mayo Clinic
Scottsdale, AZ

Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, CNSC, CPNS
Director, Center for Human Nutrition, Department of Gastroenterology
Medical Director, Intestinal Transplant
Professor of Medicine
Digestive Disease and Surgery Institute
Cleveland Clinic
Cleveland, OH

Stephen J.D. O’Keefe, MD, MSc, FRCP
Professor of Medicine
Medical Director, Small Intestinal Rehabilitation & Transplant Center
Nutrition Support Service
University of Pittsburgh
Pittsburgh, PA

Carol Rees Parrish, MS, RD
Nutritional Support Specialist
University of Virginia Health System Center
Charlottesville, VA

James S. Scolapio, MD
Professor of Medicine
Chief, Division of Gastroenterology
Program Director, Gastroenterology Fellowship
University of Florida College of Medicine
Jacksonville, FL


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Alan L. Buchman, MD, MSPH, has indicated no real or apparent conflicts.

John K. DiBaise, MD
Contracted research: GI Dynamics, Given Imaging Ltd., Takeda Pharmaceuticals North America, Inc.

Donald F. Kirby, MD
Consulting fees/advisory boards: Luitpold Pharmaceuticals, Inc., NPS Pharmaceuticals, Inc.

Stephen J.D. O’Keefe, MD, MSc, FRCP, has indicated no real or apparent conflicts.

Carol Rees Parrish, MS, RD
Ownership interest (stocks/stock options – excluding mutual funds): NPS Pharmaceuticals, Inc.
Other (Publishing): NPS Pharmaceuticals, Inc.
 

James S. Scolapio, MD, has indicated no real or apparent conflicts.

The activity planners and peer reviewers have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by an educational grant from NPS Pharmaceuticals, Inc.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.